Literature DB >> 16578552

REPLICATIVE FRAGMENTATION IN T4 PHAGE: INHIBITION BY CHLORAMPHENICOL.

A W Kozinski1, P B Kozinski, P Shannon.   

Abstract

Entities:  

Year:  1963        PMID： 16578552      PMCID： PMC221255          DOI： 10.1073/pnas.50.4.746

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  8 in total

1.  Fragmentary transfer of P32-labeled parental DNA to progeny phage. II. The average size of the transferred parental fragment. Two-cycletransfer. Repair of the polynucleotide chain after fragmentation.

Authors:  A W KOZINSKI; P B KOZINSKI
Journal:  Virology       Date:  1963-06       Impact factor: 3.616

2.  An unusual DNA extracted from bacteria infected with phage T2.

Authors:  F R FRANKEL
Journal:  Proc Natl Acad Sci U S A       Date:  1963-03-15       Impact factor: 11.205

3.  Chromosome brekage accompanying genetic recombination in bacteriophage.

Authors:  M MESELSON; J J WEIGLE
Journal:  Proc Natl Acad Sci U S A       Date:  1961-06-15       Impact factor: 11.205

4.  Fragmentary transfer of P32-labeled parental DNA to progeny phage.

Authors:  A W KOZINSKI
Journal:  Virology       Date:  1961-01       Impact factor: 3.616

5.  Phage DNA subunits in the phage precursor pool.

Authors:  A W KOZINSKI; H UCHIDA
Journal:  J Mol Biol       Date:  1961-06       Impact factor: 5.469

6.  The kinetics of parental deoxyribonucleic acid replication, deoxyguanylate kinase formation and 32P-inactivation of the parental virus in Escherichia coli infected with bacteriophage T4.

Authors:  A W KOZINSKI; M J BESSMAN
Journal:  J Mol Biol       Date:  1961-12       Impact factor: 5.469

7.  Synthesis of phage-precursor nucleic acid in the presence of chloramphenicol.

Authors:  A D HERSHEY; N E MELECHEN
Journal:  Virology       Date:  1957-02       Impact factor: 3.616

8.  The effect of chloramphenicol on deoxyribonucleic acid synthesis and the development of resistance to ultraviolet irradiation in E. coli infected with bacteriophage T2.

Authors:  J I TOMIZAWA; S SUNAKAWA
Journal:  J Gen Physiol       Date:  1956-03-20       Impact factor: 4.086
  8 in total
  16 in total

Review 1.  Antibiotics of the virginiamycin family, inhibitors which contain synergistic components.

Authors:  C Cocito
Journal:  Microbiol Rev       Date:  1979-06

2.  REPLICATIVE FRAGMENTATION IN T4 BACTERIOPHAGE DNA. II. BIPARENTAL MOLECULAR RECOMBINATION.

Authors:  A W KOZINSKI; P B KOZINSKI
Journal:  Proc Natl Acad Sci U S A       Date:  1964-08       Impact factor: 11.205

3.  THE ENZYMATIC CONDENSATION OF OLIGODEOXYRIBONUCLEOTIDES WITH POLYDEOXYRIBONUCLEOTIDES.

Authors:  C G MEAD
Journal:  Proc Natl Acad Sci U S A       Date:  1964-12       Impact factor: 11.205

4.  Late events in T4 bacteriophage production. I. Late DNA replication is primarily exponential.

Authors:  L D Kosturko; A W Kozinski
Journal:  J Virol       Date:  1976-03       Impact factor: 5.103

5.  Absence of interparental recombination in multiplicity reconstitution from incomplete bacteriophage T4 genomes.

Authors:  A W Kozinski; A H Doermann; P B Kozinski
Journal:  J Virol       Date:  1976-06       Impact factor: 5.103

6.  Transforming ability of a T4 RNA-DNA copolymer.

Authors:  L A McNicol
Journal:  J Virol       Date:  1973-08       Impact factor: 5.103

7.  T7 exonuclease (gene 6) is necessary for molecular recombination of bacteriophage T7.

Authors:  M Lee; R C Miller
Journal:  J Virol       Date:  1974-11       Impact factor: 5.103

8.  Replication and recombination in ligase-deficient rII bacteriophage T4D.

Authors:  H M Krisch; D B Shah; H Berger
Journal:  J Virol       Date:  1971-04       Impact factor: 5.103

9.  Parent-to-progeny transfer and recombination of T4rII bacteriophage.

Authors:  K Carlson; A W Kozinski
Journal:  J Virol       Date:  1970-09       Impact factor: 5.103

10.  Variations in genetic recombination due to amber mutations in T4D bacteriophage.

Authors:  H Berger; A J Warren; K E Fry
Journal:  J Virol       Date:  1969-02       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.